Table 1.
Association between ovarian malignancies and autoimmune hemolytic anemia.
| Ref. | Age | Hb (g/dL) | Histology | Metastases | Type of AIHA | Treatment | Timing of anemia | Correlation with disease activity | Cause of death | Survival from cancer diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 35 | 5 | Pseudomucinous cystadenocarcinom | No | Negative | Tumor control | 1 month prior to cancer diagnosis | - | - | - |
| 10 | 28 | 6.7 | Papillary cystadenocarcinoma | Yes | - | Steroids | 4 months after radiation/7 months after surgery/8 months after chemotherapy | - | Deconditioned, uremia | 13 months |
| 11 | 36 | 4.8 | Anaplastic carcinoma | Yes | Direct/indirect | Steroids | 2 months after cancer diagnosis/radiation/surgery | Positive | Septic shock | 6 months |
| 12 | 54 | 8 | Papillary cystadenocarcinoma | - | Negative | - | 3 months after cancer diagnosis/2 months after radiation | - | - | - |
| 13 | 64 | 4.8 | Epitheliosarcomatoid tumour | No | Direct | - | - | - | - | - |
| 14 | 57 | 6.6 | Papillary cystadenocarcinoma | Yes | Direct/indirect | Tumor control | On diagnosis | Positive | Bilateral pleural effusion/ascites/marrow suppression | 15 months |
| 15 | 29 | 7.3 | Anaplastic carcinoma | Yes | Direct | Tumor control | 1 month prior to cancer diagnosis | Positive | - | - |
| 16 | 56 | 7.4 | Papillary cystadenocarcinoma | Yes | Direct/indirect Coombe’s | Steroids temporary | 28 months after cancer diagnosis /surgery | Positive | Cerebral infarction | 35 months |
| 17 | 75 | 6.8 | Papillary cystadenocarcinoma | Yes | Direct | Steroids/tumor control | Post-chemotherapy | Positive | - | - |
| This case | 77 | 7.6 | Papillary cystadenocarcinoma | Yes | Direct | Steroids/tumor control | Post-chemotherapy | Positive | - | - |
Hb, hemoglobin; AIHA, autoimmune hemolytic anemia.